Funding for the GWTG-HF program is provided by the American Heart Association. The GWTG-HF program is supported in part by Medtronic, Ortho-McNeil, and the American Heart Association Pharmaceuticals Roundtable. GWTG-HF was funded in the past by GlaxoSmithKline. This analysis was funded by the GWTG Young Investigator Database Research Seed Grant. The sponsors of GWTG-HF had no role in the design or conduct of the study or the management, analysis, or interpretation of the data. P.L. Hess was funded by NIH T-32 training grant HL069749-09.
Age Differences in the Use of Implantable Cardioverter-Defibrillators Among Older Patients Hospitalized with Heart Failure
Version of Record online: 25 FEB 2013
© 2013 Wiley Periodicals, Inc.
Journal of Cardiovascular Electrophysiology
Volume 24, Issue 6, pages 664–671, June 2013
How to Cite
HESS, P. L., GRAU-SEPULVEDA, M. V., HERNANDEZ, A. F., PETERSON, E. D., BHATT, D. L., SCHWAMM, L. H., YANCY, C. W., FONAROW, G. C., AL-KHATIB, S. M. and for the Get with The Guidelines Steering Committee and Hospitals (2013), Age Differences in the Use of Implantable Cardioverter-Defibrillators Among Older Patients Hospitalized with Heart Failure. Journal of Cardiovascular Electrophysiology, 24: 664–671. doi: 10.1111/jce.12100
E.D. Peterson reports participation on research grants supported by Janssen Pharmaceuticals, Pfizer, and Boehringer Ingelheim. D.L. Bhatt. reports participation on research grants supported by Amarin, AstraZeneca, Bristol-Meyers Squibb, Eisai, Ethicon, Medtronic, Sanofi Aventis, The Medicines Company, as well as unfunded support from FlowCo, PLx Pharma, and Takeda. G.C. Fonarow serves as consultant/advisory board member of Novartis, Medtronic, and Gambro. Other authors: No disclosures.
- Issue online: 4 JUN 2013
- Version of Record online: 25 FEB 2013
- Accepted manuscript online: 22 JAN 2013 04:22AM EST
- Manuscript Accepted: 2 JAN 2013
- Manuscript Revised: 21 DEC 2012
- Manuscript Received: 24 AUG 2012
Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.
|jce12100-sup-00001-suppmat.docx||12K||Table S1. Variables in risk model for ICD use by age group.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.